Related Experiment Video

Updated: Jun 19, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial

Charles L Howe, Rachel A Bergstrom, Bruce F Horazdovsky

    Neurology
    |October 14, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Inguinal Subcutaneous White Adipose Tissue (ISWAT) Transplantation Model of Murine Islets10:14

    Inguinal Subcutaneous White Adipose Tissue (ISWAT) Transplantation Model of Murine Islets

    Published on: February 16, 2020

    Related Concept Videos

    Insulin: Dosing Regimen and Adverse Effects01:16

    Insulin: Dosing Regimen and Adverse Effects

    Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
    The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...